George Frangeskides, Chairman at ALBA, explains why the Pilbara Lithium option ‘was too good to miss’. Watch the video here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPantheon International Regulatory News (PIN)

Share Price Information for Pantheon International (PIN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 325.50
Bid: 324.50
Ask: 325.50
Change: 0.50 (0.15%)
Spread: 1.00 (0.308%)
Open: 324.50
High: 328.50
Low: 324.50
Prev. Close: 325.00
PIN Live PriceLast checked at -
Pantheon International is an Investment Trust

To maximise capital growth by investing in a diversified portfolio of private equity funds and occasionally directly in private companies.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Hardman & Co Research: Pantheon International Plc (PIN): Returns, resilience and responsibility

9 Oct 2020 12:00

Hardman & Co Research Hardman & Co Research: Pantheon International Plc (PIN): Returns, resilience and responsibility 09-Oct-2020 / 12:00 GMT/BST


Hardman & Co Research: Returns, resilience and responsibility

The long-term messages remain unchanged from our 6 September 2019 initiation, 11.9% average annual NAV growth since 1987: i) PIP's investors get liquid access to the whole private equity (PE) market, ii) PE-backed companies, on average, deliver superior growth than quoted ones, iii) PIP is investing in the right parts of the PE market, iv) PIP benefits from being part of the Pantheon family, and v) PIP benefits from a structured asset selection process. We believe the "real" NAV is above "book" NAV and that its downturn resilience has been proven again in 2020. PIP's ESG credentials are market-leading and well-established.

Please click on the link below for the full report:

https://www.hardmanandco.com/research/corporate-research/returns-resilience-and-responsibility/

If you are interested in meeting the company, you can register your interest by clicking on the above link

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contact:

Mark Thomas

+44 20 7194 7622

 

mt@hardmanandco.com 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 25 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

1139966 09-Oct-2020 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
11th Jan 20247:00 amRNSKepler Trust Intelligence: New Research
5th Jan 20247:00 amRNSMonthly Performance Update
2nd Jan 202411:32 amRNSTotal Voting Rights
20th Dec 20237:00 amRNSTransaction in Own Shares
15th Dec 20237:00 amRNSTransaction in Own Shares
14th Dec 20237:00 amRNSTransaction in Own Shares
12th Dec 20237:00 amRNSTransaction in Own Shares
11th Dec 20237:00 amRNSTransaction in Own Shares
8th Dec 20237:00 amRNSTransaction in Own Shares
7th Dec 20237:00 amRNSTransaction in Own Shares
6th Dec 20237:00 amRNSTransaction in Own Shares
5th Dec 20237:00 amRNSTransaction in Own Shares
4th Dec 20237:00 amRNSTransaction in Own Shares
24th Nov 20237:00 amRNSMonthly Performance Update
1st Nov 202310:39 amRNSTotal Voting Rights
30th Oct 202312:53 pmRNSHolding(s) in Company
23rd Oct 202311:22 amRNSHolding(s) in Company
20th Oct 20237:00 amRNSMonthly Performance Update
19th Oct 20231:12 pmRNSResult of AGM
19th Oct 202310:00 amRNSCOMPLETION OF TENDER OFFER AND TOTAL VOTING RIGHTS
19th Oct 20237:00 amRNSRefinanced Credit Facility
18th Oct 20238:18 amRNSResult of Tender Offer
28th Sep 202312:06 pmRNSInvestor Presentation
25th Sep 20237:00 amRNSTender Offer
22nd Sep 20237:00 amRNSMonthly Performance Update
19th Sep 202312:41 pmRNSHolding(s) in Company
1st Sep 202312:16 pmRNSTotal Voting Rights
1st Sep 20237:00 amRNSTransaction in Own Shares
25th Aug 20237:00 amRNSMonthly Performance Update
24th Aug 20237:00 amRNSTransaction in Own Shares
23rd Aug 20237:00 amRNSTransaction in Own Shares
22nd Aug 20237:00 amRNSTransaction in Own Shares
14th Aug 20237:00 amRNSTransaction in Own Shares
11th Aug 20234:00 pmRNSQuotedData's Weekly News & Interview
11th Aug 20237:00 amRNSTransaction in Own Shares
10th Aug 20235:22 pmRNSDirector/PDMR Shareholding
10th Aug 20237:00 amRNSTransaction in Own Shares
9th Aug 202310:51 amRNSDirector/PDMR Shareholding
8th Aug 20232:54 pmRNSDirector/PDMR Shareholding
8th Aug 202311:59 amRNSDirector/PDMR Shareholding
8th Aug 20237:00 amRNSTransaction in Own Shares
7th Aug 20235:24 pmRNSDirector/PDMR Shareholding
4th Aug 20235:22 pmRNSTransaction in Own Shares
4th Aug 20234:32 pmRNSDirector/PDMR Shareholding
4th Aug 20232:36 pmRNSDirector/PDMR Shareholding
3rd Aug 20234:37 pmRNSTransaction in Own Shares
3rd Aug 20233:44 pmRNSNotice of AGM
3rd Aug 202311:45 amRNSShare Buyback Programme
3rd Aug 20237:00 amRNSAnnual Financial Report
31st Jul 202312:54 pmRNSAppointment of Joint Corporate Broker

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.